Zobrazeno 1 - 10
of 33
pro vyhledávání: '"E C, Reed"'
Autor:
R W, Carlson, B O, Anderson, W, Bensinger, C E, Cox, N E, Davidson, S B, Edge, W B, Farrar, L J, Goldstein, W J, Gradishar, A S, Lichter, B, McCormick, L M, Nabell, E C, Reed, S M, Silver, M L, Smith, G, Somlo, R, Theriault, J H, Ward, E P, Winer, A, Wolff
Publikováno v:
Oncology (Williston Park, N.Y.). 14(11A)
The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. In many situations, the patient and physician have the responsibility to jointly explore and ultimately select the most appropriate option from am
Publikováno v:
Bone marrow transplantation. 18(1)
The T cell-mediated antineoplastic activity observed following allogeneic transplantation and the suggestion of improved therapeutic efficacy by autologous peripheral stem cell transplantation (PSCT) as compared to autologous bone marrow transplantat
Autor:
J M, Vose, P J, Bierman, E, Ruby, E C, Reed, M R, Bishop, S, Tarantolo, A, Kessinger, J O, Armitage
Publikováno v:
Bone marrow transplantation. 17(6)
We evaluated the differences in engraftment and toxicities post-autologous transplant using granulocyte-macrophage colony stimulating factor (GM-CSF) as a continuous infusion either alone or in a sequential manner with granulocyte colony-stimulating
Autor:
E C, Reed
Publikováno v:
The Nebraska medical journal. 81(3)
The benefits of adjuvant systemic therapy in the treatment of early breast cancer are well established. However, many questions remain regarding the appropriate selection of patients and regimens, duration of treatment, timing or sequencing of treatm
Autor:
J E, Talmadge, E C, Reed, A, Kessinger, C A, Kuszynski, G A, Perry, C L, Gordy, K C, Mills, M L, Thomas, S J, Pirruccello, B A, Letheby, M A, Arneson, J D, Jackson
Publikováno v:
Bone marrow transplantation. 17(1)
The immunologic attributes of cytokine mobilized peripheral blood stem cell (PSC) products (n = 52) and the resulting reconstitution of the hematopoietic and immunologic system following autologous transplantation were examined in a consecutive popul
Autor:
W D, Haire, E I, Ruby, B G, Gordon, K D, Patil, L C, Stephens, G D, Kotulak, E C, Reed, J M, Vose, P J, Bierman, A, Kessinger
Publikováno v:
JAMA. 274(16)
To define the frequency and outcome of organ dysfunction in bone marrow transplantation (BMT) and to determine if patients with organ dysfunction have lower levels of protein C (PC) and/or antithrombin III (ATIII) than those without organ dysfunction
Autor:
A, Kessinger, M R, Bishop, J D, Jackson, B, O'Kane-Murphy, J M, Vose, P J, Bierman, E C, Reed, P I, Warkentin, J O, Armitage, J G, Sharp
Publikováno v:
Experimental hematology. 23(7)
A trial to determine the usefulness of recombinant human erythropoietin (rhEpo) as a mobilizing cytokine for patients with previously treated relapsed malignancies was performed. An initial peripheral stem cell apheresis collection was conducted duri
Publikováno v:
Bone marrow transplantation. 13(5)
Transient mucositis occurs in almost all patients receiving bone marrow transplantation (BMT) but it is not known whether airway mucociliary transport is impaired during this period. We hypothesized that the preparative regimen associated with BMT im
Publikováno v:
Bone marrow transplantation. 13(5)
Phase I and II trials have demonstrated that high-dose chemotherapy with autologous hematopoietic stem cell rescue is effective 'consolidation' chemotherapy for patients with responding metastatic breast cancer. In this study 26 women with metastatic
Publikováno v:
The American journal of medicine. 96(4)
Diffuse alveolar hemorrhage is a frequent complication of treating malignancies with high-dose chemotherapy and bone marrow transplantation and is associated with very high mortality. This disorder's association with pulmonary inflammation, its coinc